Beatriz Grinsztejn, MD, PhD

Dr. Beatriz Grinsztejn is an infectious disease physician and researcher with over 30 years of dedication to HIV prevention and care. She is the Head of the Fiocruz STI/AIDS Clinical Research Laboratory and the Fiotrials Prevention and Therapeutic Clinical Trials Unit, where she leads research focused on advancing the prevention, treatment, and care of HIV, STIs, and emerging infections. Under her leadership, the CTU is affiliated with major international networks, including HPTN and ACTG.  Dr.

Ntando Yola

Ntando Yola is the Stakeholder and Community Engagement Lead at the University of Cape Town Clinical Trials Unit and the Desmond Tutu Health Foundation in Cape Town. His vast experience of HIV, TB, and related clinical research demonstrated his dedication to mobilising and facilitating an enabling environment for diverse stakeholders to have a meaningful role in health research and development.

Mitch M. Matoga, MD, MSc, PhD

Dr. Matoga is a physician with training in infectious disease epidemiology and implementation science. He is an assistant professor of medicine at UNC Chapel Hill. He directs the STI research and clinical services program and leads the implementation science research unit at UNC Project-Malawi. He has over 15 years of experience conducting research in HIV, STIs and implementation science. Dr.

Kenneth Ngure, MPH, MSc, PhD

Kenneth Ngure MPH, MSc, PhD is a an Associate Professor of Global Health at the School of Public Health Jomo Kenyatta University of Agriculture and Technology and an Affiliate Associate Professor at the Department of Global Health University of Washington. His research mainly focuses on novel biomedical HIV prevention methods from clinical trials to delivery focusing on differentiated service delivery approaches to increase coverage.